Xuemei Wu
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Non-HDL-C, Symptomatic Intracranial Arterial Stenosis, and Recurrent Vascular Risk in Minor Stroke.
Journal: Journal of atherosclerosis and thrombosis
Published: September 04, 2024
Evaluation of intracranial atherosclerotic stenosis burden, the use of dual antiplatelet therapy, and stroke recurrence in patients with minor stroke.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 02, 2024
Dual Versus Mono Antiplatelet Therapy in Patients with Acute Mild-to-Moderate Stroke: A Multicentre Perspective Cohort Study.
Journal: Cardiovascular drugs and therapy
Published: May 09, 2023
Minor stroke patients with mild-moderate diastolic blood pressure derive greater benefit from dual antiplatelet therapy.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: April 04, 2023
Triglyceride-glucose index, symptomatic intracranial artery stenosis and recurrence risk in minor stroke patients with hypertension.
Journal: Cardiovascular diabetology
Published: February 06, 2023
Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke.
Journal: Frontiers in neurology
Published: September 25, 2022
Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke.
Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke.
Journal: Frontiers in neurology
Published: May 06, 2022
Evaluation of the association between admission systolic blood pressure and the choice of initial antiplatelet therapy for minor ischemic stroke in real-world.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: December 12, 2021
Dual versus mono antiplatelet therapy in mild-to-moderate stroke during hospitalization.
Journal: Annals of clinical and translational neurology
Published: August 06, 2021
Intranasal treatment of lixisenatide attenuated emotional and olfactory symptoms via CREB-mediated adult neurogenesis in mouse depression model.
Journal: Aging
Published: August 24, 2020
Last Updated: 09/26/2026